Contracts With Doctors:

Similar documents
Mitigating the Growing Risk Posed by the FCPA and Global Anti-Bribery Regulations

Physician Payment Transparency Provisions of the Affordable Care Act Sunshine 101

Responding to Commercial Bribery Investigations What to Do When the Chinese Administration for Industry and Commerce (AIC) Arrives At Your Door

HIPAA Privacy Rule and Research

Efficient use of orbit/spectrum by satellite systems - the impact of fees

Medicaid and Access To Care: Implications of DRA. Donna A. Boswell November Be Careful What You Wish For

Strategic and Operational Challenges Resulting from the New PPACA

Directors and Officers Liabilities in Russia

Successful Dealmaking in Today s Challenging Environment: What you need to know

Shareholders' Rights in a Russian Joint-Stock Company

Third Party Rights / Licence. Binding Framework. Negotiating Framework

Roundtable on Anti-Bribery and Anti- Corruption Compliance in Latin America Latin American Anti-Corruption Laws

MiFID II 31 December MiFID II

FRAUD AND ABUSE LAW IMPLICATED BY COMPENSATION ARRANGEMENTS. Lee Rosebush, PharmD, RPh, MBA, JD

American Academy of Orthopaedic Surgeons 2010 Annual Meeting. March 12, 2010

Arbitrability of IP Disputes in Russia

MiFID II. Inducements. Key Points

Firms will be required to appoint a single officer with specific responsibility for client assets

The Act Amending the Right of Inquiry

Industry Funding of Continuing Medical Education

Bogies: Federal Anti- Kickback Law & EMS Contracting - Emerging Issues Pamela L. Johnston Foley & Lardner LLP Partner, Los Angeles.

Latham & Watkins Health Care Practice Group

MiFID II 31 December MiFID II

Grey areas in the spotlight Update on Investment Regulations Non-public companies

Latham & Watkins Corporate and Litigation Departments. CMS Issues Proposed Regulations Interpreting the Physician Payment Sunshine Act

Every cent counts: China slashes certain IP application fees. April 2017

MiFID II March MiFID II

MiFID II Best execution and client order handling

The Ninth Annual Pharmaceutical Regulatory Compliance Congress and Best Practices Forum

MiFID II 31 December MiFID II

MiFID II 18 January MiFID II

MiFID II 31 December MiFID II

MiFID II 31 December MiFID II. Derivatives: trade execution

Association of Corporate Counsel January 2012 Teleconference CMS Finally Issues Proposed Sunshine Act Regulations

Contents. Introduction 4. Directors conflicts duties 4. What is a conflict? 5. Who can authorise? 6. Authorising conflicts 7

Government, Industry and Health Profession Compliance Guidance: Welcome to the Era of Ethics and Transparency

Directors duties under the Companies Act An introduction

Current Issues in Patient and Product Support. October 20, 2016

The PSC register. The requirement for a register of persons with significant control over UK entities

Derivatives: trade execution

MiFID II 31 December MiFID II. Third country access

MiFID II 31 December MiFID II

DEPARTMENT OF HEALTH AND HUMAN SERVICES. Office of Inspector General s Use of Agreements to Protect the Integrity of Federal Health Care Programs

Client Alert. CMS Announces Final Regulations Interpreting the Physician Payment Sunshine Act. A. Definitions and Exclusions

2014 Lathrop & Gage LLP Lathrop & Gage LLP Lathrop & Gage LLP

New listing regime proposals for emerging and innovative companies

Much Ado About Arrangements: Compliance Perspectives on Conflicts of Interest in Physician Relationships

NEW CHANNEL OPENED FOR FLOWING-BACK OF OVERSEAS RENMINBI ("RMB")

Sec of the SUPPORT for Patients and Communities Act

SEC adopts requirement for disclosure of hedging policies for employees, officers, and directors

MiFID II 31 December MiFID II. Commodity derivatives

MiFID II Information to clients on costs and charges

The Anesthesia Company Model: Frequently Asked Questions

A New Frontier Amendments to the Listing Rules, Prospectus Rules and Disclosure and Transparency Rules

Law Amendment and the FCPA Best Practices for Responding to a Chinese Government Commercial Bribery Investigation

Recent Developments In Voluntary Disclosure Stark Law

ABA Mutual Institutions Council Capital Issues for Mutuals

Independent Contractor Issues after SB 459 Presented by Daniel B. Pasternak. 37 Offices in 18 Countries

Stark Self-Referral Disclosure Protocol

Observations on US LNG Export Prospects in Latin America Eduardo Carvajal, Hogan Lovells US-Americas LNG Forum I, Rio de Janeiro, Brazil May 23, 2018

Health Law 101: Issue-Spotting In Dealing With Health-Care Providers. by William H. Hall Jr.

The Perils Of Pharma: The Pharmaceutical Industry And The FCPA

Certifying Employee Training Navicent Health s Corporate Integrity Agreement Year Two

Hogan Lovells (Luxembourg) LLP. What do you know about us?

MiFID II 31 December MiFID II. Information to clients on costs and charges

Notice ; Request for Comments Regarding Participation by Tax-Exempt Hospitals in Accountable Care Organizations

Establishing an Anti-Corruption Compliance Program in Canada

English High Court Limits Scope of Privilege for Documents Generated During the Course of Internal Investigations

U.S. v. Sulzbach: Government Theories, Potential Defenses, and Lessons Learned

Mar. 31, 2011 (202) Federal agencies address legal issues regarding Accountable Care Organizations

2012 Health Law Education Program: Anatomy of a Self- Disclosure Telling CMS About Your Stark Law Problems

FAIR MARKET VALUE & COMMERCIAL REASONABLENESS

Listing in London An introductory guide

Overview of Pay For Performance

FTC/DOJ ISSUE JOINT PROPOSED STATEMENT OF ANTITRUST ENFORCEMENT POLICY RELATING TO ACOs

Transparency reports (Sunshine Act)

Anti-Kickback Statute Compliance in Healthcare Transactions

The Anti-Kickback Statute. May 3, 2013 Tennessee Hospice Organization Compliance Forum

Goals of the Presentation. ACO Compliance Planning: Navigating 1/22/2016. Disclaimer

EMPLOYMENT & COMPLIANCE ISSUES & PITFALLS IN CROSS- BORDER M&A TRANSACTIONS

HIPAA s New Rules: Expanding Scope, Clarifying Uncertainties, and Reinforcing Fundamentals

Latham & Watkins Corporate Department

MEMORANDUM FOR THE NATONAL STRUCTURED SETTLEMENTS TRADE ASSOCIATION

Recent Developments in Foreign Corrupt Practices

HKMA reboots virtual banking. February 2018

It s Here: The Final 60 Day Overpayment Rule

Payment Services Academy

RESPIRONICS, INC. CONTRACTING WITH HEALTHCARE PROFESSIONALS OR PROVIDERS AND REFERRAL SOURCES POLICY

Contracting with Specialty Pharmacies and Hubs 17 th Annual Pharma and Medical Device Compliance Congress. October 20, 2016

HUMAN TRAFFICKING COMPLIANCE

AHLA. F. Anti-Kickback Primer. David E. Matyas Epstein Becker & Green PC Washington, DC

Will Life Sciences Companies Face More Scrutiny In 2018?

Self-Disclosure: Why, When, Where and How

The Impact of the Fraud and Abuse Laws on Pharmaceutical Advertising and Marketing Compliance: A Manufacturer s Perspective

Medical Device Compliance Issues Update

Physician Contracting An Overview of Legal Policy No. 9

M&A ACADEMY: TAX ISSUES IN M&A TRANSACTIONS

Case KRH Doc 2682 Filed 06/14/16 Entered 06/14/16 19:08:42 Desc Main Document Page 1 of 23

Hospital Incentive Payments to Physicians for Quality and Cost Savings

TAX ISSUES IN M&A TRANSACTIONS

Transcription:

Contracts With Doctors: Not Just a U.S. Compliance Issue Anymore First International Medical Device Compliance Congress and Best Practices Forum May 27, 2008 Hogan & Hartson LLP. All rights reserved.

U.S. Hip and Knee Industry 5 companies (Zimmer, DePuy, Biomet, Smith & Nephew and Stryker) account for nearly 95% of market More than 700,000 total hip and knee replacement surgeries performed in U.S. each year (HHS) Approximately 2/3 of implant patients are Medicare beneficiaries Physicians control selection of devices, but typically do not bear the cost Hogan & Hartson LLP. All rights reserved. 2

Role of Surgeon Consultants Product Design Product Evaluation Surgeon Education and Training Sales Force Education Research Hogan & Hartson LLP. All rights reserved. 3

The Investigation Commencement: Grand jury subpoenas issued to five largest orthopedics companies in late March 2005 by the U.S. DOJ through the U.S. Attorney s Office for the District of New Jersey (USAO) The Focus: Consulting agreements with, and payments to, orthopedic surgeons Duration: Two-and-a-half years Hogan & Hartson LLP. All rights reserved. 4

The Allegations According to the Office of Inspector General From 2002-2006, 4 manufacturers paid over $800 million under 6,500 physician consulting agreements Vague descriptions of services rendered, sometimes drafted by sales reps $5,000 per quarter for reports on market trends, OR activity and product issues that were cursory often duplicated from quarter to quarter and of little or no value Panel presentations at resorts; $5,000 for a 10 minute presentation Training for experienced sales reps; full day billed for 1-2 hour sessions Product design teams with up to 20 physicians, some added after project more than halfway completed Hogan & Hartson LLP. All rights reserved. 5

The Resolution Criminal Complaints: Filed against 4 of the 5 companies, alleging conspiracy to violate the federal anti-kickback statute, in violation of 18 U.S.C. 371 Alleged conduct: [E]ntering into financial arrangements with orthopedic surgeons who were offered or who solicited payments from [Company], in part, for the surgeons use of [Company s] hip and knee joint reconstruction and replacement products, from in or about January 2002 to in or about December 2006. Hogan & Hartson LLP. All rights reserved. 6

The Resolution Deferred Prosecution Agreements: Prosecution of criminal complaints deferred for 18- month term of DPA, provided the Company does not breach a material provision of the DPA Dismissal upon expiration of the DPA No statement of facts or admission of wrongdoing According to USAO press release, Stryker avoided DPA, and entered into NPA, due to early cooperation. Civil Settlement Agreements with payments totaling $311 million 5-Year Corporate Integrity Agreements Hogan & Hartson LLP. All rights reserved. 7

Requirement: Monitor Duties & Authority Access to all non-privileged documents deemed reasonably necessary Authority to meet with any employee or agent Review and evaluate all policies, practices and procedures relating to retention and payment of consultants Approve annual needs assessment Veto power over any consulting arrangements or payments Quarterly reports to USAO, to include recommendations to enhance future compliance Hogan & Hartson LLP. All rights reserved. 8

Requirement: Consultant and Payment Disclosures Website disclosures: DPA/NPA posting Consultants, City & State Payments in $25k increments In-kind compensation Consulting agreements must require consultant disclosures to patients and affiliated hospitals. Hogan & Hartson LLP. All rights reserved. 9

Requirement: Needs Assessment Annual needs assessment, as approved by the Monitor, to define and limit all consulting services Including written support for the needs Must also Include budget for educational grants, gifts and donations Incorporate detailed protocols or procedures to be followed before a consulting agreement will be authorized Hogan & Hartson LLP. All rights reserved. 10

Requirement: Consulting Agreements In writing and executed by Compliance Officer, CEO, General Counsel and other senior managers No agreements through third parties, including distributors Limited to calendar year term, except for product development, clinical and research agreements Must identify specific services and rates Hogan & Hartson LLP. All rights reserved. 11

Requirement: Consultant Payments Hourly rates capped at $500 for time actually expended, absent independent FMV analysis (i.e., no retainers) Company employee or representative present for all services, except with Monitor approval (e.g., data collection, travel or prep time) Company representative and consultant verifications under penalty of perjury as condition of payment Hogan & Hartson LLP. All rights reserved. 12

Requirement: Royalties Must be justified by contributions to development of intellectual property Product design teams limited to those reasonably necessary to achieve design and development needs Aggregate royalties under product development agreements may not exceed FMV expressed as percentage of sales Advance and minimum royalties prohibited No royalties beyond life of U.S. patent No royalties on a Consultant s own use of product Commercially reasonable fixed amounts permitted in lieu of royalties for the transfer of IP Hogan & Hartson LLP. All rights reserved. 13

Other Requirements No payments for research or collection of data without written protocol No funding of fellowships for fellows who work with health care professionals (HCPs), except to legitimate medical education institutions or foundations No charitable donations to organizations controlled by HCPs or their immediate family members, or where an immediate family member of a HCP is employed Hogan & Hartson LLP. All rights reserved. 14

Compliance Officer s Role Oversight, evaluation and approval of needs assessment Approval of consulting services budget and all payments Evaluation of each new proposed consultant Execution of all consulting agreements Approval of fellowships and charitable contributions, in consultation with the Monitor Hogan & Hartson LLP. All rights reserved. 15

The Aftermath SEC/Justice Foreign Corrupt Practices Act inquiries Payments to government-employed physicians in foreign countries New Jersey USAO focus shifts from large to smaller orthopedic manufacturers Subpoenas to Wright Medical and Exactech Individual surgeons also under scrutiny Association of American Medical Colleges Task Force recommends banning gifts, food and travel, and strongly discouraging speaker bureau participation Physician Payments Sunshine Act New Justice Department guidelines for monitor appointments Hogan & Hartson LLP. All rights reserved. 16

One Company s Response Zimmer Announces Comprehensive Compliance Reform Program Ban on all gifts to health care professionals No longer sponsoring physician presentations at professional society meetings Eliminating satellite institutes at customer locations Physicians receiving royalties may no longer serve as trainers Annual donation to third-parties for all education and resident/fellowship funding Standardizing compliance polices across all business units worldwide Hogan & Hartson LLP. All rights reserved. 17

For more information on Hogan & Hartson, please visit us at www.hhlaw.com Ronald L. Wisor Jr. Hogan & Hartson LLP Washington, D.C. rlwisor@hhlaw.com +1.202.637.5658 Baltimore Beijing Berlin Boulder Brussels Caracas Colorado Springs Denver Geneva Hong Kong London Los Angeles Miami Moscow Munich New York Northern Virginia Paris Shanghai Tokyo Warsaw Washington, DC Hogan & Hartson LLP. All rights reserved. 18